Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control

Affiliations

• ¹ MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda; Department of Global Health and Amsterdam Institute for Global Health and Development, Amsterdam University Medical Centers, Amsterdam, Netherlands; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK.
• ² MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda; The Jenner Institute, Old Road Campus Research Building, Oxford, UK; Department of Immunology and Molecular Biology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda. Electronic address: beatrice.nassanga@gmail.com.
• ³ MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
• ⁴ The Jenner Institute, Old Road Campus Research Building, Oxford, UK; Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxford, Oxford, UK.
• ⁵ The Jenner Institute, Old Road Campus Research Building, Oxford, UK.
• ⁶ MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK.
• ⁷ Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.